Boston Scientific
BSX
930 hedge funds and large institutions have $60.4B invested in Boston Scientific in 2022 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 329 increasing their positions, 316 reducing their positions, and 59 closing their positions.
142% more first-time investments, than exits
New positions opened: 143 | Existing positions closed: 59
32% more funds holding in top 10
Funds holding in top 10: 22 → 29 (+7)
19% more capital invested
Capital invested by funds: $50.9B → $60.4B (+$9.46B)
7% more funds holding
Funds holding: 866 → 930 (+64)
4% more repeat investments, than reductions
Existing positions increased: 329 | Existing positions reduced: 316
0.53% less ownership
Funds ownership: 91.64% → 91.11% (-0.53%)
33% less call options, than puts
Call options by funds: $203M | Put options by funds: $303M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$825M |
| 2 |
BlackRock
New York
|
+$351M |
| 3 |
Morgan Stanley
New York
|
+$296M |
| 4 |
SCM
Steadfast Capital Management
New York
|
+$130M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$111M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$345M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$287M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$208M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$185M |
| 5 |
JP Morgan Chase
New York
|
-$139M |
BSX Hedge Fund Activity: Q4 2022 in Review
930 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2022, worth a combined $60.4B — up 19% from $50.9B a quarter earlier.
Buyers outnumbered sellers: 143 funds opened new BSX positions and 59 closed out — a net gain of 84 holders — while 329 added to existing stakes and 316 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $825M. The largest seller was Citadel Advisors, cutting an estimated $345M.
- 930 institutional investors held Boston Scientific (BSX) as of Q4 2022, up from 866 in Q3 2022.
- Funds reported $60.4B of Boston Scientific stock for Q4 2022, up 19% quarter-over-quarter.
- 143 funds opened new Boston Scientific positions in Q4 2022 and 59 closed out, a net change of +84 holders.
- The largest Boston Scientific buyer in Q4 2022 was Fidelity Investments, an estimated $825M added.
- The largest Boston Scientific seller in Q4 2022 was Citadel Advisors, an estimated $345M sold.
Based on aggregated 13F filings for Q4 2022.